Journals / Romatizma Dergisi / 2006 / Cilt: 21 - Sayı: 3

Coexistence of ankylosing spondylitis and multiple sclerosis: A case report

Ankilozan spondilit ve multipl skleroz birlikteliği: Olgu sunumu

Pages
114–117
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this paper, an ankylosing spondylitis patient who developed the typical symptoms of multiple sclerosis during the follow-up was presented and the comorbidity was discussed in the view of current literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The neurological symptoms are rarely seen in patients with ankylosing spondylitis.
📊
Key Findings & Data:Underlying reasons usually include progressive arachnoiditis, cauda equina syndrome, atlanto-axial subluxation and spinal fractures.
💡
Conclusion & Impact:In this paper, an ankylosing spondylitis patient who developed the typical symptoms of multiple sclerosis during the follow-up was presented and the comorbidity was discussed in the view of current literature.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Multipl skleroz · Spondilit · ankilozan

Abstract

The neurological symptoms are rarely seen in patients with ankylosing spondylitis. Underlying reasons usually include progressive arachnoiditis, cauda equina syndrome, atlanto-axial subluxation and spinal fractures. In addition, the observation of multiple sclerosis-like symptoms and signs in some patients with ankylosing spondylitis has drawn attention to the coexistence of these two diseases. In this paper, an ankylosing spondylitis patient who developed the typical symptoms of multiple sclerosis during the follow-up was presented and the comorbidity was discussed in the view of current literature.

Özet

Ankilozan spondilitli hastalarda nörolojik semptomlar ender olarak görülmektedir. Altta yatan nedenler genellikle ilerleyici araknoidit, kauda ekina sendromu, atlantoaksiyel subluksasyon ve spinal kırıklar şeklindedir. Ayrıca bazı ankilozan spondilitli hastalarda multipl skleroz benzeri semptom ve bulguların görülmesi, bu iki hastalığın birlikteliği üzerinde durulmasına neden olmuştur. Bu yazıda ankilozan spondilit tanısı ile izlenmekte iken tipik multipl skleroz semptomları gelişen bir olgu sunulmuş ve güncel literatür ışığında iki hastanın birlikteli ği tartışılmıştır.

🔖

Cite This Article

KARATEPE, A. G., KAYA, T., GEDİZOĞLU, M., GÜNAYDIN, R., ÜRPER, S. (2006). Coexistence of ankylosing spondylitis and multiple sclerosis: A case report. Romatizma Dergisi, Cilt: 21 - Sayı: 3, 114–117. https://ajindex.com/articles/305924

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Khan MA. Ankylosing spondylitis: clinical features. In: Klippel JH, Dippe PA (eds) Rheumatology 2nd edition, vol 1. London: Mosby, 1998: 6.16: 1-10
  2. Mathews WB. The neurological complication of ankylosing spondylitis. J Neurol Sci 1968; 4:561-73
  3. Calin A. Is there an association between ankylosing spondylitis and multiple sclerosis? Ann Rheum Dis 1989; 48:971-2
  4. Hanrahan PS, Russell AS, McLean DR. Ankylosing spondylitis and multiple sclerosis: An apparent association? J Rheumatol 1988; 15:1512-4
  5. Khan MA, Kushner I. Ankylosing spondylitis and multiple sclerosis. Arthritis Rheum 1979; 22:784-6
  6. Libbrecht N, De Bleecker J. Ankylosing spondylitis and multiple sclerosis. Acta Clin Belg 1999; 54:30-2
  7. Cellerini M, Gabbrielli S, Bongi SM. Cerebral magnetic resonance imaging in a patient with ankylosing spondylitis and multiple sclerosis-like syndrome. Neuroradiology 2001; 43:1067-9
  8. Tan FU, Tellioğlu S, Aydin G, Erdemoğlu AK, Kelefl I. Ankylosing spondylitis in an HLA-B27 negative patient. Acta Neurol Belg 2004; 104:169-72
  9. Oh DH, Jun JB, Kim HT, Lee SW, Jung SS, Lee IH, et al. Transverse myelitis in a patient with long-standing ankylosing spondylitis. Clin Exp Rheumatol 2001; 19:195-6. 10.Atalay F. Steroid olmayan antiinflamatuar ilaçlar. In: Beyazova M, Gökçe Kutsal Y (eds) Fiziksel Tıp ve Rehabilitasyon, Cilt 1. Ankara: Güneş Kitabevi Ltd Şti, 2000: 4.1:685-705. 11.Akıncı A. Yavafl etkili ilaçlar. In: Beyazova M, Gökçe Kutsal Y (eds) Fiziksel Tıp ve Rehabilitasyon, Cilt 1. Ankara: Güneş Kitabevi Ltd Şti, 2000: 4.2:706-19. 12.Vezmar S, Becker A, Bode U, Jaehde U. Biochemical and clinical aspects of methotrexate neurotoxicity. Chemotherapy 2003; 49:92-104. 13.Ledingham J, Deightan C. Update on the British Society for Rheumatology guidelines for prescribing TNFα blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001). Rheumatology (Oxford) 2005; 44:157-63. 14.Thomas DJ, Kendall MJ, Whitfield AG. Nervous system involvement in ankylosing spondylitis. Br Med J 1974; 1:148. 15.Whitman GJ, Khan MA. Unusual occurrence of ankylosing spondylitis and multiple sclerosis in a black patient. Cleve Clin J Med 1989; 56:819-22. 16.McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50:121-7. 17.Dyment DA, Sadovnick AD, Ebers GC. Genetics of mul